Publications by authors named "Paolo Muto"

Claim this Profile
I
Impact of whole-brain radiation therapy on neurocognitive functions, alopecia and hearing loss: a systematic review and meta-analysis endorsed by the Palliative Care and Neuro-Oncology Study Groups of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Rossella Di Franco, Donato Pezzulla, Silvia Chiesa, Francesco Cellini, Ettore Rocchi, Paolo Muto

Radiol Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating dosimetric outcomes: a comparison of CyberKnife, VMAT FFF, and Helical Tomotherapy Radixact for treating localized prostate cancer.
Gaetano Gagliardo, Marcello Serra, Gianluca Ametrano, Marco Galiero, Cecilia Arrichiello, Paolo Muto

Radiol Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation quality matters: morphological and biochemical responses of Brassica rapa microgreens to X-rays, C-ions, and Fe-ions.
Sara De Francesco, Chiara Amitrano, Ermenegilda Vitale, Giulia Costanzo, Walter Tinganelli, Paolo Muto

Planta· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial.
Piet Ost, Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, Paolo Muto

Lancet Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer.
Vincenzo Iorio, Pietro Delia, Angela Pia Solazzo, Ivan Fazio, Antonino Daidone, Matteo Muto, Paolo Muto

Anticancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial.
Piet Ost, Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, Paolo Muto

Eur Urol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ionizing radiation on cell-ECM mechanical crosstalk in breast cancer.
Rocco Mottareale, Crescenzo Frascogna, Giuseppe La Verde, Cecilia Arrichiello, Paolo Muto

Front Bioeng Biotechnol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team working.
Alessandro Morabito, Edoardo Mercadante, Paolo Muto, Anna Manzo, Giuliano Palumbo

Explor Target Antitumor Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the mechanical microenvironment on CD-44 expression of breast adenocarcinoma in response to radiotherapy.
Crescenzo Frascogna, Rocco Mottareale, Giuseppe La Verde, Cecilia Arrichiello, Paolo Muto

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers.
Luca Bergamaschi, Maria Giulia Vincini, Mattia Zaffaroni, Matteo Pepa, Ilaria Angelicone, Matteo Muto, Paolo Muto

Support Care Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy of orbital metastases: a systematic review of management and treatment outcomes on behalf of palliative care study group of Italian association of radiotherapy and clinical oncology (AIRO).
Donato Pezzulla, Rossella Di Franco, Alice Zamagni, Francesco Pastore, Silvia Longo, Paolo Muto

Br J Radiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy with CyberKnife System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
Valentina Borzillo, Esmeralda Scipilliti, Donato Pezzulla, Marcello Serra, Gianluca Ametrano, Paolo Muto

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spine Instability Neoplastic Score (SINS) as a Predictive Tool in Conventional Radiotherapy: A Narrative Review.
Donato Pezzulla, Alessia Re, Savino Cilla, Milena Ferro, Carmela Romano, Paolo Muto

Cancer Invest· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.
Alessandro Ottaiano, Antonella De Luca, Mariachiara Santorsola, Giosuè Scognamiglio, Annabella Di Mauro, Paolo Muto

BMC Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis.
Alessandro Morabito, Edoardo Mercadante, Paolo Muto, Giuliano Palumbo, Anna Manzo

JCO Oncol Pract· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives.
Alessandro Ottaiano, Mariachiara Santorsola, Luisa Circelli, Anna Maria Trotta, Francesco Izzo, Paolo Muto

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Thermoluminescence Dosimetry for QA in High-Dose-Rate Skin Surface Brachytherapy with Custom-Flap Applicator.
Francesco Manna, Mariagabriella Pugliese, Francesca Buonanno, Federica Gherardi, Eva Iannacone, Paolo Muto

Sensors (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reirradiation on spine metastases: an Italian survey on behalf of palliative care and reirradiation study groups of Italian association of radiotherapy and clinical oncology (AIRO).
Rossella Di Franco, Donato Pezzulla, Fabio Arcidiacono, Antonio Pontoriero, Francesco Cellini, Paolo Muto

Clin Transl Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Paolo Muto

J Transl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy.
Andrea Emanuele Guerini, Marianna Noale, Gianluca Mortellaro, Roberto Lisi, Alessio Bruni, Paolo Muto

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis.
Domenico Mallardo, Diana Giannarelli, Maria Grazia Vitale, Domenico Galati, Giusy Trillò, Paolo Muto

J Immunother Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription.
Francesco Cellini, Alessia Di Rito, Giambattista Siepe, Francesco Pastore, Elisabetta Lattanzi, Paolo Muto

Adv Radiat Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization.
Domenico Mallardo, Ester Simeone, Vito Vanella, Maria Grazia Vitale, Marco Palla, Paolo Muto

J Transl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation therapy affects YAP expression and intracellular localization by modulating lamin A/C levels in breast cancer.
Giuseppe La Verde, Valeria Artiola, Mariagabriella Pugliese, Marco La Commara, Cecilia Arrichiello, Paolo Muto

Front Bioeng Biotechnol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurbinectedin in small cell lung cancer.
Anna Manzo, Vincenzo Sforza, Guido Carillio, Giuliano Palumbo, Agnese Montanino, Paolo Muto

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis